501 related articles for article (PubMed ID: 15537844)
1. Recent advances in diabetic nephropathy.
Marshall SM
Postgrad Med J; 2004 Nov; 80(949):624-33. PubMed ID: 15537844
[TBL] [Abstract][Full Text] [Related]
2. Management of nephropathy in patients with type 2 diabetes.
Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
[TBL] [Abstract][Full Text] [Related]
3. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
Bretzel RG
Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
[TBL] [Abstract][Full Text] [Related]
5. Diabetic nephropathy.
Ritz E
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
[TBL] [Abstract][Full Text] [Related]
6. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.
Araki S; Haneda M; Koya D; Kashiwagi A; Uzu T; Kikkawa R
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S54-8. PubMed ID: 18947896
[TBL] [Abstract][Full Text] [Related]
8. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
Luño J; Valderrábano F
An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
[No Abstract] [Full Text] [Related]
9. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
Agha A; Bashir K; Anwar E
Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
[TBL] [Abstract][Full Text] [Related]
10. Diabetic renal disease: microalbuminuria, implications and intervention.
Savage MW; Leese GP; Vora JP
Nutrition; 1995; 11(6):761-4. PubMed ID: 8719137
[TBL] [Abstract][Full Text] [Related]
11. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
Abuissa H; O'Keefe J
Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
[TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
Chantrel F; Bouiller M; Kolb I; Hannedouche T
Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
15. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
Remuzzi G; Macia M; Ruggenenti P
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
[TBL] [Abstract][Full Text] [Related]
17. Preserving the diabetic kidney.
Poirier SJ
J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
[TBL] [Abstract][Full Text] [Related]
18. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
Rossing P
Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844
[TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
Basi S; Lewis JB
Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288
[TBL] [Abstract][Full Text] [Related]
20. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
